Juvenile OLFM4 Null Mice Are Protected from Sepsis.
暂无分享,去创建一个
H. Wong | K. Stringer | P. Devarajan | J. Stark | A. Opoka | J. Mallela | Q. Ma | N. C. Levinsky | Matthew N. Alder | M. Alder
[1] Ó. Peñuelas,et al. Histopathological changes of organ dysfunction in sepsis , 2019, Intensive Care Medicine Experimental.
[2] M. Miyazaki,et al. OLFM4 Enhances STAT3 Activation and Promotes Tumor Progression by Inhibiting GRIM19 Expression in Human Hepatocellular Carcinoma , 2019, Hepatology communications.
[3] H. Wong,et al. Olfactomedin 4 marks a subset of neutrophils in mice , 2018, Innate immunity.
[4] M. van Meurs,et al. Kidney histopathology in lethal human sepsis , 2018, Critical Care.
[5] T. Kuijpers,et al. Neutrophils as myeloid‐derived suppressor cells , 2018, European journal of clinical investigation.
[6] P. Kubes,et al. Neutrophil heterogeneity: Bona fide subsets or polarization states? , 2018, Journal of leukocyte biology.
[7] P. Kubes. The enigmatic neutrophil: what we do not know , 2018, Cell and Tissue Research.
[8] H. Wong,et al. Olfactomedin-4 Is a Candidate Marker for a Pathogenic Neutrophil Subset in Septic Shock , 2017, Critical care medicine.
[9] R. Bellomo,et al. Renal perfusion in sepsis: from macro- to microcirculation. , 2017, Kidney international.
[10] Outcomes,et al. Acute Kidney Injury in Pediatric Severe Sepsis: An Independent Risk Factor for Death and New Disability , 2016 .
[11] R. Bellomo,et al. Histopathology of Septic Acute Kidney Injury: A Systematic Review of Experimental Data , 2016, Critical care medicine.
[12] J. Faith,et al. Neutrophil ageing is regulated by the microbiome , 2015, Nature.
[13] Rinaldo Bellomo,et al. Epidemiology of acute kidney injury in critically ill patients: the multinational AKI-EPI study , 2015, Intensive Care Medicine.
[14] F. Staal,et al. Olfactomedin 4 Serves as a Marker for Disease Severity in Pediatric Respiratory Syncytial Virus (RSV) Infection , 2015, PloS one.
[15] E. Seeley,et al. Increased expression of neutrophil-related genes in patients with early sepsis-induced ARDS. , 2015, American journal of physiology. Lung cellular and molecular physiology.
[16] Derek Wheeler,et al. Global epidemiology of pediatric severe sepsis: the sepsis prevalence, outcomes, and therapies study. , 2015, American journal of respiratory and critical care medicine.
[17] H. Saito,et al. A New Cecal Slurry Preparation Protocol with Improved Long-Term Reproducibility for Animal Models of Sepsis , 2014, PloS one.
[18] Kiran Hebbar,et al. Pediatric Severe Sepsis: Current Trends and Outcomes From the Pediatric Health Information Systems Database* , 2014, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.
[19] Hans Clevers,et al. Robust Cre-Mediated Recombination in Small Intestinal Stem Cells Utilizing the Olfm4 Locus , 2014, Stem cell reports.
[20] J. Marshall. Why have clinical trials in sepsis failed? , 2014, Trends in molecular medicine.
[21] R. Hotchkiss,et al. The changing immune system in sepsis , 2013, Virulence.
[22] Wenli Liu,et al. Olfm4 deletion enhances defense against Staphylococcus aureus in chronic granulomatous disease. , 2013, The Journal of clinical investigation.
[23] A. Karlsson,et al. The Human Neutrophil Subsets Defined by the Presence or Absence of OLFM4 Both Transmigrate into Tissue In Vivo and Give Rise to Distinct NETs In Vitro , 2013, PloS one.
[24] Yueqin Liu,et al. Olfactomedin 4 Inhibits Cathepsin C-Mediated Protease Activities, Thereby Modulating Neutrophil Killing of Staphylococcus aureus and Escherichia coli in Mice , 2012, The Journal of Immunology.
[25] A. Silahtaroglu,et al. Olfactomedin 4 defines a subset of human neutrophils , 2012, Journal of leukocyte biology.
[26] Yi Huang,et al. Depletion of OLFM4 gene inhibits cell growth and increases sensitization to hydrogen peroxide and tumor necrosis factor-alpha induced-apoptosis in gastric cancer cells , 2012, Journal of Biomedical Science.
[27] Rajit K. Basu,et al. Identification of candidate serum biomarkers for severe septic shock-associated kidney injury via microarray , 2011, Critical care.
[28] B. Thornhill,et al. Proximal tubular injury and rapid formation of atubular glomeruli in mice with unilateral ureteral obstruction: a new look at an old model. , 2011, American journal of physiology. Renal physiology.
[29] P. Grover,et al. Stem cell marker olfactomedin 4: critical appraisal of its characteristics and role in tumorigenesis , 2010, Cancer and Metastasis Reviews.
[30] Yueqin Liu,et al. Olfactomedin 4 down-regulates innate immunity against Helicobacter pylori infection , 2010, Proceedings of the National Academy of Sciences.
[31] W. Mccune,et al. IFNsVascular Damage and Synthesizes Type I Systemic Lupus Erythematosus Induces Neutrophils Isolated from Patients with A Distinct Subset of Proinflammatory , 2010 .
[32] R. Bellomo,et al. Pathophysiology of septic acute kidney injury: What do we really know? , 2008, Critical care medicine.
[33] Wenli Liu,et al. The glycoprotein hGC-1 binds to cadherin and lectins. , 2006, Experimental cell research.
[34] R. Hotchkiss,et al. The pathophysiology and treatment of sepsis. , 2003, The New England journal of medicine.